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QuasispeciesDuring the summer of 2007, an outbreak of equine viral arteritis (EVA) occurred in Normandy (France). After
investigation, a link was suggested between an EAV carrier stallion (A) and the index premise of the out-
break. The full-length nucleotide sequence analysis of a study reference strain (F27) isolated from the lung
of a foal revealed a 12,710 nucleotides EAV genome with unique molecular hallmarks in the 5′UTR leader se-
quence and the ORF1a sequence encoding the non-structural protein 2. The evolution of the viral population
in the persistently infected Stallion A was then studied by cloning ORFs 3 and 5 of the EAV genome from four
sequential semen samples which were collected between 2000 and 2007. Molecular analysis of the clones
conﬁrmed the likely implication of Stallion A in the origin of this outbreak through the yearly emergence
of new variants genetically similar to the F27 strain.
© 2011 Elsevier Inc. All rights reserved.Introduction
Equine arteritis virus (EAV) is the causative agent of equine viral
arteritis (EVA), and a member of the family Arteriviridae within the
order Nidovirales (Cavanagh, 1997; Snijder and Spaan, 2006). EVA is
a reproductive and respiratory disease in horses and other equid spe-
cies (Doll et al., 1957a, 1957b; McCollum and Swerczek, 1978). The
genome is a positive-stranded 3′-polyadenylated RNA of approxi-
mately 12.7 kb in length, with ten known open reading frames
ﬂanked by the 5′ untranslated regions (5′UTR) and 3′UTR (Firth et
al., 2011; Snijder and Meulenberg, 1998; Snijder et al., 1999). The
5′-terminal leader sequence is an untranslating sequence present in
the 5′-proximal region of all genomic and subgenomic mRNAs (van
den Born et al., 2005). The 5′-three-quarters of the genome (ORFs
1a and 1b) encode two replicase polyproteins, which are post-
translationally processed by three ORF1a-encoded proteinases
(nsp1, -2 and -4) in order to yield at least 13 non-structural proteinsmbe, 1 route de Rosel, 14053
czak).
rights reserved.(nsp1 to -12, including nsp7α and 7β) (Snijder and Meulenberg,
1998; van Aken et al., 2006; van Dinten et al., 1996; Ziebuhr et al.,
2000). The remaining 3′-quarter contains eight ORFs which encodes
eight structural proteins: E, GP2, GP3, GP4, 5a, GP5, M and N respec-
tively (de Vries et al., 1992; Snijder and Spaan, 2006; Wieringa et
al., 2002). The envelope contains two major viral proteins: the ungly-
cosylated membrane protein M and the variable major envelope gly-
coprotein GP5 which confers different neutralization phenotypes
(Balasuriya et al., 1999, 2001; Hedges et al., 1999). Consequently,
the ORF 5 is the most widely used for phylogenetic analysis, and glob-
al EAV strains can be grouped into two clades: the North American
group and the European group which can be divided into two differ-
ent subgroups named EU-1 and EU-2 (Balasuriya et al., 1995, 1999;
Larsen et al., 2001; Metz et al., 2011; Mittelholzer et al., 2006;
Pronost et al., 2010; Zhang et al., 2007, 2010).
Exposure to EAV usually results in a mild or subclinical infection in
immunocompetent animals. Clinical signs of EAV infected horses can
vary in range and severity, and the vast majority of these EAV infec-
tions are unapparent. Equine viral arteritis is frequently characterized
by inﬂuenza-like signs in adult horses, but can also cause abortion in
pregnant mares, interstitial pneumonia in young foals and death in
newborn foals (McCollum et al., 1999; Timoney and McCollum,
166 F. Miszczak et al. / Virology 423 (2012) 165–1741993). A variable percentage (up to 10%–70%) of the stallions acutely
infected with EAV can subsequently become carriers and continue to
shed the virus in their semen. Carrier stallions are the natural reser-
voir of EAV and the virus persists in the reproductive tract, principally
in the ampulla of the vas deferens (Timoney and McCollum, 1993).
They are central to the epidemiology of the disease and they can po-
tentially transmit the virus to susceptible mares during artiﬁcial in-
semination or natural breeding (Timoney, 1986; Timoney et al.,
1986).
During the summer of 2007, an EAV outbreak occurred in the
lower and upper regions of Normandy, France. Only draught and sad-
dle horses were affected on 18 infected premises. This study is based
on preliminary investigation of a known long-term EAV carrier stal-
lion and his link with the index premise of the outbreak. Therefore,
we worked on the hypothesis that the source of the 2007 EVA out-
break in France stemmed from an EAV strain present in the semen
of this carrier stallion. The primary objective of the study was to un-
dertake molecular characterization of the EAV strain associated with
this outbreak and to compare its molecular hallmarks to the virus
present in the semen of the carrier stallion in order to conﬁrm the or-
igin of this EVA outbreak. A second objective was to study the genetic
evolution of the virus present in this stallion from 2000 to 2007.
Results
Retrospective investigation
In 2000, screening of serum samples from a stallion, named Stal-
lion A and located in a Normandy stud farm (SF-A), was diagnosed se-
ropositive for antibodies to EAV. This stallion was then conﬁrmed in
2001 as a chronic EAV shedder by demonstrating viral nucleic acids
in semen by standard RT-PCR. On April 6th and 28th, 2007, a Mare
B was brought to the Index Premise 61 named IP61 for two separateFig. 1. Schematic depiction of the location of premises to which the EAV infection spreads in
Seine Maritime) and Lower Normandy (14: Calvados, 50: Manche, 61: Orne). Links between
semen and animal movements concerning Stallion A and Mare B (with dates of artiﬁcial ins
which samples were collected, and squares and circles in grey represent respectively primar
sion (month, year). The stud farms A and B are named SF-A and SF-B, the index premise is na
corresponding area's number.artiﬁcial inseminations with two samples of fresh-cooled semen col-
lected in 2007 from Stallion A (Fig. 1). Upon returning to her stud
farm (SF-B), Mare B then became ill after the ﬁrst insemination of
April 11th, 2007, and the EAV infection was conﬁrmed by serological
testing. During both artiﬁcial inseminations at the index premise
(IP61), Mare B was in close contact with a teaser horse, Stallion C,
which became infected after the second artiﬁcial insemination and
was declared ill on May 6th, 2007. Then Stallion C remained at IP61
in close contact with four other stallions (D, E, F and G). On June
25th, 2007, the IP61 was conﬁrmed EAV infected and ofﬁcially desig-
nated as the onset of the outbreak following the death of Stallion D.
Between May 16th and June 27th, 2007, fresh-cooled semen from
the four Stallions D, E, F and G was sent for artiﬁcial insemination to
the Primary Premises PP27 and PP61-1. The ﬁrst established case of
mortality due to EAV was observed at the PP61-1 in a very young
foal (R), and is considered in this study as the “study reference EAV
strain” named F27.
Characterization of nucleotide hallmarks of the F27 EAV strain circulat-
ing during the 2007 French EVA outbreak
The full-length of the F27 “study reference strain” is 12,710 nucle-
otides (nt) in length, 2 nucleotides longer than the CW96 strain
(12,708 nt, EU-2 phylogenetic subgroup, GenBank ID AY349167),
and 6 nucleotides longer than the EAV030 reference virus (12,704
nt, North American phylogenetic group (NA), GenBank ID Y07862)
(Balasuriya et al., 2004; van Dinten et al., 1997). The F27 strain had
a 87.0% and 86.0% nucleotide identity on full genome sequences com-
pared respectively to the CW96 and EAV030 strains. The greatest var-
iations among the structural proteins were observed in the
glycoproteins GP5, GP3, and GP4, which presented respectively a
85.5%, 85.8% and 87.1% nucleotide identity compared to the EAV030
strain. The greatest variations among the replicase proteins, occurredNormandy, France. This region is divided in ﬁve different areas in Upper (27: Eure, 76:
the different premises are represented by full grey and black arrows, and fresh-cooled
eminations) are in black broken arrows. The black squares represent the premises from
y and secondary premises that were subsequently infected, with date of EAV transmis-
med IP, the 8 primary premises (PP) and the 9 secondary premises (SP), followed by the
167F. Miszczak et al. / Virology 423 (2012) 165–174in the nsp3, nsp2 and nsp7 proteins, which presented respectively a
80.8%, 81.8% and 83.1% nucleotide identity, compared to the pub-
lished sequence of the EAV030 strain.
The F27 full-length sequence revealed four insertions and one de-
letion in the genome: one 2-nucleotide insertion (nt numbers T-119
and T-120), two 1-nucleotide insertions (T-156 and C-160) and a
single 1-nucleotide deletion (G-138) in its 5′UTR leader sequence,
as well as a consecutive 3-nucleotide insertion (nt G-1458, G-1459,
C-1460) in a highly variable region of the nsp2 gene. Complementary
molecular analyses were performed on the 5′UTR leader and nsp2
regions with respectively 54 and 51 sequences collected from the
GenBank database and in this study. The analysis revealed that the
2-nucleotide insertion (T-119 and T-120) had never been described
in scientiﬁc literature, unlike the two 1-nucleotide insertions and
the single deletion in the 5′ leader sequence which had ever been ob-
served in previous studies (Fig. 2A) (Balasuriya et al., 2004; Van Den
Born et al., 2004). In the analysis of nsp2 sequences, collected se-
quences were as follow: 28 sequences collected from GenBank data-
base and 23 sequences from strains of this study (4 strains from
Stallion A (F60-F63), 11 strains collected during the outbreak (F27-
F67), and 8 before the outbreak between 2001 and 2006 (F10, F15,
F68-F73)) (Fig. 2B). Of the 54 sequences, 25 belonged to the EU-2Fig. 2. Alignment and nucleotide variations of partial nucleotide sequences of the 5′UTR
sequences of the 5′UTR leader and the nsp2 regions were aligned, collected from the Ge
F44, F60-F63, F67-F73) (ﬁrst and second columns). Alignments were performed using V
column corresponds to the phylogenetic group (NA, North American group; EU-1, Eur
2010; Zhang et al., 2007, 2010). The nucleotides were numbered according to their po
(van Dinten et al., 1997). Panel A: frameworks correspond to insertions and deletion in
Panel B: framework corresponds to insertion in the sequences collected in this study, co
nucleotide insertions (G, glycine; D, aspartic acid, V, valine) and corresponding strains.subgroup, 23 to the EU-1 subgroup and 6 to the North American
group. The consecutive 3-nucleotide insertion in position nt 158 to
160 was only observed in sequences from strains belonging to the
EU-2 subgroup and was absent in the other clades. Sequences
obtained from strains collected from Stallion A and during this
2007 EAV outbreak revealed a speciﬁc “GGC” insertion resulting in
the insertion of a glycine [G] in position 152 in the nsp2 amino acid
sequence. At the same position, 8 sequences from strains collected
in France between 2001 and 2006 were characterised by a “GAC” in-
sertion encoding an aspartic acid [D], and 2 previously published se-
quences (CW96 and CW01) collected from GenBank revealed a
“GTC” insertion encoding a valine [V] (Balasuriya et al., 2004).
Characterization of EAV strains from Stallion A
Stallion A was known since 2000 as being EAV positive. The four
strains collected from this stallion between 2000 and 2007 (F60-F63)
were subjected to the full-length genome sequencing and theywere re-
spectively 12,710 nucleotides in length (F60), and 12,722 nucleotides
(F61, F62, F63). Analysis of these sequences revealed the same inser-
tions and deletion in the 5′UTR leader and nsp2 sequences of those ob-
served in the F27 sequence. Chromatograms of these sequencesleader region (A) and the nsp2-coding region in ORF1a (B). Respectively 54 and 51
nBank database and this study (F10, F15, F27, F28, F30, F32, F34, F38, F40, F41, F43,
ector NTI Advance® v11.5.1 (Invitrogen-Life Technologies, Carlsbad, CA). The third
opean subgroup 1; EU-2, European subgroup 2; U, Undetermined) (Pronost et al.,
sition in the published sequence of EAV030 virus (GenBank accession no. Y07862)
the sequences collected in this study, compared to the EAV030 reference sequence.
mpared to the EAV030 reference sequence. Amino acids are translated from the 3-
Fig. 3. Nucleotide variations observed on ORF3 (A) and ORF5 (B) in the different clones obtained from F60, F61, F62 and F63 viral populations (Stallion A) and compared to the study reference F27 sequence. Clones are named by viral pop-
ulation (F60 to F63), then by cloned ORF (-3 or -5) and then by number of clone in the studied viral population (c#). The nucleotides were numbered according to their position in the published sequence of EAV030 virus (GenBank accession
no. Y07862) (van Dinten et al., 1997). Only differences were scored. Dots indicate sequence identity. Variations in the F27 sequence, consensus sequences of F60 to F63 viral populations and in-frame 12-nucleotide insertion in ORF3 are in
grey. Non-silent nucleotide mutations, compared to the F27 sequence, are underlined. The number of different clones was determined by comparison with the total number of obtained clones in each viral population (F60, F61, F62 and 63).
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Fig. 3 (continued).
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Fig. 4. Amino acid variations observed on ORF3 (A) and ORF5 (B) in the different clones obtained from F60, F61, F62 and F63 viral populations (Stallion A) and compared to the study reference F27 sequence. Clones are named by viral
population (F60 to F63), then by cloned ORF (-3 or -5) and then by number of clone in the studied viral population (c#). The amino acids were numbered according to their position in the published sequence of EAV030 virus (GenBank
accession no. Y07862) (van Dinten et al., 1997). Only differences were scored. Dots indicate sequence identity. Variations in the F27 sequence, consensus sequences of F60 to F63 viral populations and in-frame 4-amino acids insertion in
ORF3 are in grey. The number of different clones was determined by comparison with the total number of obtained clones in each viral population (F60, F61, F62 and 63).
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Fig. 5. A) Phylogenetic tree of the partial ORF5 sequences of 388 EAV strains, 66 sequences were collected from this study (26 from EAV strains and 40 clones from F60, F61, F62 and
F63 strains) and 322 sequences were previously published (Pronost et al., 2010; Zhang et al., 2007, 2010). B) Enlarged dendrogram of the FR2007 cluster and the phylogenetically
closed EAV strains of this cluster. F60 to F63 strains corresponding to consensus sequences from viral populations F60 to F63 collected from Stallion A in 2000, 2001 and 2007, are
indicated by arrows. Phylogenetic analyses were constructed using MEGA4.1. Values resulting from bootstrap analysis are indicated adjacent to the major branching points.
171F. Miszczak et al. / Virology 423 (2012) 165–174revealed some nucleotide positions with ambiguities (various possible
nucleotides), which suggests that F60 to F63 full-length genome se-
quences represent consensus sequences of multiple variants in the
same strain. Analysis of the ORF3 and ORF5 sequences of the F60 to
F63 strains revealed respectively 8, 13, 34 and 36 ambiguities observed
on the ORF3, as well as 2, 6, 31 and 36 ambiguities on the ORF5, which
show that the number of ambiguities increased between 2000 and 2007
(Figs. 3A and B). Analysis of full-length genomes also revealed a consec-
utive in-frame 12-nucleotide insertion in the ORF3 sequence of the F61,
F62 and F63 consensus sequences, which was unobserved in other
strains and unfound in scientiﬁc literature. In these F61 to F63consensus sequences, the 12-nucleotide insertions were located be-
tween nt 10647 and 10648 according to EAV030 sequence, and were
genetically similarwhen compared together (F61: 5′GCGAAACCACTC3′,
F62: 5′GCGAAACCAYTT3′, F63: 5′GCRAAACCAYWT3′), and resulted in
the insertion of 4 amino acids (F61: AKPL, F62: AKP(L/F), F63: AKP(L/
H/Y/F)) (Figs. 3A and 4A).
Genetic evolution of strains in the persistently infected Stallion A
In order to study the viral population distribution, PCR products of
variable and complete ORF3 (492 bp) and ORF5 (768 bp) sequences
172 F. Miszczak et al. / Virology 423 (2012) 165–174were cloned from F60 to F63 viral populations of Stallion A. 72 clones
were obtained: 32 clones on ORF3 and 40 clones on ORF5, they were
sequenced, analysed and compared with the F27 sequence as refer-
ence. Analysis revealed two 1-nucleotide insertions in ORF5 from
the clones F60-5c10 (nt T-11547) and F61-5c05 (nt C-11469), conse-
quently causing a stop codon in the reading frame (Fig. 3B). Molecular
analysis of the ORF5 sequences from the clones revealed that the
number of genetically different clones inside each viral population
F60 to F63 was 5 out of 10 (F60), 9 out of 12 (F61), 10 out of 10
(F62), and 8 out of 8 (F63). Molecular analysis of the ORF3 sequences
from the clones F60 to F63 revealed the presence of variants with the
in-frame 12-nucleotide insertion between nt 10647 and 10648
(Fig. 3A). Therefore, this 12-nucleotide insertion in the ORF3 was
not present in the reference F27 sequence. Regarding the clones de-
rived from ORF3, 5 out of 7 (F60), 12 out of 12 (F61), 9 out of 9
(F62), and 3 out of 4 (F63) were found to be genetically different.
These ﬁndings indicate that the number of different clones increased
from year to year with a more and more heterogeneous viral popula-
tion. For viral populations F60 and F63 (on ORF3) and F60 and F61
(on ORF5), several clones were identical and would represent a
major variant within these viral populations. However, in viral popu-
lations F61 and F62 (on ORF3) and F62 and F63 (on ORF5), all clones
were unique and no major variant could be distinguished (Figs. 3A
and B). Comparison of each clone to the F27 sequence revealed that
the genetically closer clones in each viral population (F60-F63)
were F60-3c07, F61-3c09, F62-3c07 and -3c08 and F63-3c03 and
-3c04 which had respectively a 97.4%, 98.2%, 99.4% and 99.8% nucleo-
tide identity on ORF3. Likewise, on ORF5, the F60-5c07, F61-5c12,
F62-5c08 and F63-5c06 clones had respectively a 96.6%, 97.3%,
99.1% and 99.5% nucleotide identity (Figs. 3A and B). This ﬁnding re-
veals that some of the variants of the quasispecies were, on a yearly
basis, increasingly genetically closer to the F27 strain. Furthermore,
two clones obtained on ORF3 and ORF5 (F62-3c07 and F63-5c06),
both collected in 2007, revealed a 100% amino acid identity with
the F27 sequence (Figs. 4A and B). Compared to the F27 nucleotide
sequence, of the 32 clones obtained on ORF3, 542 mutations were ob-
served: 198 silent mutations and 344 non-silent mutations corre-
sponding to 337 amino acid changes. Of the 40 clones obtained on
ORF5, 881 nucleotide mutations were observed, 626 silent mutations
and 255 non-silent mutations corresponding to 218 amino acid
changes (Figs. 3 and 4).
Phylogenetic analysis of EAV strains related to the 2007 French EVA out-
break and variants obtained from Stallion A
Based on the phylogenetic analysis of 388 nucleotide sequences of
the partial ORF5, an unrooted phylogenetic tree was obtained and
EAV strains clustered into three distinct groups: the North American
group and the two European subgroups EU-1 and EU-2. All EAV
strains related to the 2007 French EVA outbreak clustered inside the
European subgroup-2 (EU-2) into the FR2007 group (Fig. 5A). Fur-
thermore, an enlarged dendrogram of the cluster FR2007 and strains
phylogenetically closed conﬁrmed that the FR2007 cluster includes all
of the EAV strains from the outbreak (Fig. 5B). It also includes the F62
and F63 viral populations collected from Stallion A in 2007 with all of
the clones obtained from these two strains. Other clones, obtained
from the F60 and F61 strains collected in 2000 and 2001, were phylo-
genetically related to the FR2007 cluster but grouped outside of the
cluster, with the eight strains received by the Frank Duncombe Labo-
ratory between 2001 and 2006 and two other strains W877 and A755
collected from horses in Germany in 1994 and 1995.
Discussion
During the French EVA outbreak, the virus subsequently spread to
premises in Normandy from mid-June, 2007, and continued until mid-August. The origin of the outbreak had yet to be identiﬁed and it had
been hypothesized that a persistently infected stallion could be the
source of the infection by the emergence of a new variant which
might becomemore pathogenic (Pronost et al., 2010). Based on a retro-
spective investigation concerning horses implicated in the putative ori-
gin of the outbreak, a link has been established between the persistently
infected Stallion A and the index premise. In order to conﬁrm whether
the stallion is responsible for precipitating this extensive EVA outbreak
in France, we performed extensive sequence and phylogenetic analyses
of EAV strain present in the semen of this carrier stallion aswell as virus
strains present in the animals with clinical signs of EVA. Full-length se-
quencing of the F27 reference study strain revealed an EAV genome
12,710 nt longer than the EAV030 reference strain (12,704 nt), and
shorter than EAV strains associated with the US 2006/2007 occurrence
(12,731 nt) (Zhang et al., 2010). Furthermore, molecular characteriza-
tion of the F27 strain and EAV strains associated with the 2007 disease
occurrence showed some interesting and characteristic insertions in the
5′UTR leader and the nsp2 sequences. Further analysis revealed that the
ﬁrst insertion of 2 nucleotides (nt positions 119 and 120) in the 5′UTR
leader region had never been described in scientiﬁc literature or depos-
ited in GenBank, that it is speciﬁc to strains circulating in France, and be-
longs to the EU-2 subgroup. Interestingly, the 3-nucleotide insertion in
nsp2 region also constitutes a genetic marker of the European
subgroup-2. Moreover, speciﬁc insertion of the 3 nucleotides “GGC”
encoding for a Glycine represents a molecular hallmark of the strains
collected during the 2007 French EAV outbreak. Genetic analysis on
consensus sequences F60 to F63 from Stallion A revealed that these
two speciﬁc molecular hallmarks, observed in the 5′ leader and the
nsp2 sequences of the F27 strain,were both present in strains from Stal-
lion A. Furthermore, the increasing number of ambiguities in the con-
sensus sequences of viral populations from F60 to F63 suggests that
these consensus sequences represent a more and more heterogeneous
mutant swarm. These heterogeneous populations containing genetical-
ly non-identical, but related variants, are commonly termed quasispe-
cies, which are characterised by a dynamic evolution under selective
pressures. The extension of quasispecies is due to a distribution of se-
quences and mutation is not occasional but a continuous event, partic-
ularly during chronic or persistent infections. Interestingly, mutations
can occur in individual components of a mutant spectrum without
change in the average or consensus sequence. This is fuel for viral dis-
ease emergences, since viral quasispecies may provide more ﬁt or
more pathogenic variants ready to be selected and to cause an epidemic
(Domingo, 2010).
Several studies had previously shown that the genetic and pheno-
typic variations of EAV occurred during persistent infection of stal-
lions (Balasuriya et al., 2004; Hedges et al., 1999; Zhang et al.,
2010). The investigation on the four viral populations from Stallion
A has clearly demonstrated the dynamic evolution of a viral popula-
tion over a period of 8 years to one or several variants genetically
closed to the F27 strain circulating during the outbreak. Phylogenetic
analysis has also established the evolution of viral population for Stal-
lion A, where some variants emerged genetically similar to the epi-
demic F27 strain. Molecular analysis of clones on the ORFs 3 and 5
indicates that EAV quasispecies evolve considerably in the semen of
the carrier stallion during a long-term persistent infection. Full-
length sequencing of F61 to F63 has revealed a 12-nucleotide inser-
tion in the ORF3 which was not present in the F27 reference se-
quence, therefore cloning of these F60-F63 viral populations
revealed variants without this insertion, genetically similar to the
F27 strain. The description of viral quasispecies has often been per-
formed on small amplicons (b0.5 kb) on other viruses; in this study,
analysis of these two genomic segments constitutes a longer and suf-
ﬁcient size to increase the analytical power and reveals a greater
complexity of viral swarm (Smith et al., 1997). Viral quasispecies con-
stitute a reservoir of genetic and phenotypic variants, with several bi-
ological implications for viral evolution and pathogenesis. One sees
173F. Miszczak et al. / Virology 423 (2012) 165–174that variants are genetically more and more different with time; for
instance, inside each quasispecies, some of the variants were, on a
yearly basis, increasingly genetically closer to the F27 strain. These
ﬁndings and the emergence of new variants in Stallion A, where
some of which have a 99.8% and 99.5% nucleotide identity with F27
strain on ORF3 and ORF5, strongly indicate that Stallion A is most
probably at the origin of this outbreak, particularly as two clones
revealed a 100% identity on the amino acids sequence.
This study conﬁrms that EAV viral RNA evolves in persistently
infected stallions, and that 5′UTR leader region and nsp2, GP3 and
GP5 genes are involved in the variations of the EAV genome. In order
to trace the origin of the outbreak, it is vital to carry out sequential anal-
ysis, to compare the virus strains and tomonitor their propagation. Fur-
thermore, this study conﬁrms the importance of keeping trace of EAV
carrier stallions. These stallions constitute the natural reservoir of
EAV, which then ensures its persistence in various horse populations
throughout the world; they can also be the cause of new infection at
the origin of outbreak. These ﬁndings reinforce the importance to mon-
itor, and ﬁnd treatments for EAV persistent carrier stallions. Efforts con-
tinuing into devising a safe and effective therapeutic means of
eliminating the carrier state in the stallion are necessary and could con-
siderably reduce the transmission of EAV and the emergence of patho-
genic strains as a potential source of new outbreaks.
Materials and methods
Samples
This study included 27 clinical samples collected in France over a
period of 8 years (2000 to 2007): 4 sequential semen samplesTable 1
Background data of 27 French EAV molecular strains collected in this study.
Strain
ID
Sample
source
Specimen
type
Collection
date
Premise GenBank ID
F60 Stallion A Semen 23-Feb-00 SF-A JN211317
F61 Stallion A Semen 29-Mar-01 SF-A JN211318
F15 Stallion I Semen 8-Oct-01 Unknown JN211321; EF492553
F10 Stallion H Semen 28-Jan-03 Unknown JN211322; EF492548
F68 Stallion J Semen 21-Oct-03 Unknown JN211347; JN211348
F70 Stallion L Semen 26-Apr-06 Unknown JN211351; JN211352
F71 Stallion M Semen 26-Apr-06 Unknown JN211353; JN211354
F73 Stallion O Semen 26-Sep-06 Unknown JN211357
F69 Stallion K Semen 3-Oct-06 Unknown JN211349; JN211350
F72 Stallion N Semen 19-Oct-06 Unknown JN211355; JN211356
F28 Stallion D Testis 1-Jun-07 IP61 JN211323; JN211324
F29 Mare P Nasal swab 5-Jun-07 SP27-1 JN211325
F30 Mare Q Nasal swab 5-Jun-07 SP27-1 JN211326; JN211327
F27 Foal R Lung 15-Jun-07 PP61-1 JN211316
F65 Mare S Nasal swab 19-Jun-07 SP27-1 JN211343
F32 Mare T Lung 22-Jun-07 SP27-1 JN211328; JN211329
F34 Foal U Lung 24-Jun-07 SP27-1 JN211330; JN211331
F38 Stallion E Semen 27-Jun-07 IP61 JN211332; JN211333
F40 Stallion F Semen 27-Jun-07 IP61 JN211334; JN211335
F41 Stallion G Semen 27-Jun-07 IP61 JN211336; JN211337
F43 Foal V Nasal swab 27-Jun-07 SP27-1 JN211338; JN211339
F44 Foal W Lung 27-Jun-07 SP27-1 JN211340; JN211341
F66 Foal X Nasal swab 27-Jun-07 SP27-1 JN211344
F64 Stallion C Semen 27-Jun-07 IP61 JN211342
F67 Foal Y Nasal swab 6-Jul-07 SP27-1 JN211345; JN211346
F62 Stallion A Semen 25-Jul-07 SF-A JN211319
F63 Stallion A Semen 10-Sep-07 SF-A JN211320
Strains are arranged by collection date from February 2000 to September 2007 and
named non-exhaustively from F10 to F73 (“F” for French strains and numbers accord-
ing to Pronost et al., 2010). First part of the table (from February 2000 to October 2006)
corresponds to strains collected before the outbreak and the second part (from June
2007 to September 2007) corresponds to strains collected during the outbreak. The
three premises, IP61: Index Premise 61, PP61-1: Primary Premise 61-1 and SP27-1:
Secondary Premise 27-1, are epidemic premises located in Normandy. The four strains
(F60-F63) from the persistently infected Stallion A and the "study reference strain"
named F27, were all completely sequenced.collected from the persistently infected Stallion A (2000, 2001 and
twice in 2007), 15 samples (4 semen, 6 nasal swabs and 5 organs)
from three of the ﬁrst premises infected (IP61, PP61-1 and SP27-1)
and 8 semen samples received at the Frank Duncombe Laboratory be-
tween 2001 and 2006 which were selected since they belonged to the
EAV European subgroup-2 (EU-2) (Table 1).RNA extraction
Viral RNA was extracted from ﬂuid samples (semen and nasal
swab) using the QIAamp® Viral RNA isolation kit, and from organ
samples (lung, liver and testicle) with 10% tissue suspensions using
the RNeasy® Mini Kit, according to the manufacturer's instructions
(Qiagen, Hilden, Germany).Reverse transcription (RT) and PCR ampliﬁcation
In order to cover the full-length of the EAV genome, viral RNA was
ﬁrst reverse-transcribed into cDNA using SuperScript™ III Reverse
Transcriptase (Invitrogen, Carlsbad, CA) following the manufacturer's
instructions, and then ampliﬁed by using forward and reverse
primers described in Table 2. PCRs were carried out in a ﬁnal volume
of 50 μl containing 2.5 μl of the cDNA, 10 μl of 5× Phusion HF buffer,
1 μl of dNTP mix (10 mM each), 1.2 μl of each primer (20 μM), 0.5 μl
of Phusion™ Hot Start High-Fidelity DNA polymerase (Finnzymes,
Espoo, Finland), and 33.6 μl of nuclease-free water. The thermal pro-
ﬁle included initial denaturation at 98 °C for 30 s, followed by 40 cy-
cles of denaturation at 98 °C for 10 s, annealing at 60 °C for 30 s, and
extension at 72 °C for 30s–2 min (depending on the ﬁnal PCR product
size), and a ﬁnal extension at 72 °C for 10 min. Prior to sequencing,
PCR products were gel-puriﬁed then both sense and anti-sense
strands were sequenced (Euroﬁns MWG Operon, Huntsville, AL).Cloning
The entire ORFs 3 and 5 of the four semen samples collected from
Stallion A (F60-63) were ampliﬁed with ﬂanking primers (10142P–
10952N and 10763P–11995N) (Table 2). The PCR products were
cloned into the pDrive Cloning Vector and transformed into EZ Com-
petent Cells using the Qiagen® PCR Cloningplus Kit (Qiagen, Hilden,
Germany) according to the manufacturer's instructions. The nucleo-
tide sequences of the clones obtained in this study were deposited
in GenBank under accession numbers JN211358–JN211429.Table 2
Primers used for Reverse Transcription, PCR ampliﬁcation and cloning of EAV genome.
Primer Polarity Position Nucleotide sequence (5′-3′)
1P2 + 1–21 GCTCGAAGTGTGTATGGTGCC
2169P + 2169–2190 CGTTGCTGGAGATGCTTCGGAC
2463N − 2482–2463 CGCTTCCACATGACATTGAG
3051N − 3051–3030 CCCAAGGAAACACAAGCAACAC
4805P + 4805–4825 AGAGGTAACAGCTGGAGACCG
5198N − 5217–5198 CTTCCTGATGCTCCACGTAA
7391P + 7391–7411 TGGTTCTGTGGCAATTGTGTC
7468N − 7487–7468 AAGTGGAGCGGTACATGATG
8907N − 8926–8907 CGCTGAGCACGGTTTACTGA
9745P + 9745–9767 CGTGTGATGGGCTTAGTGTGGTC
9817N − 9838–9817 AGAAAAGCGCTGCATCAATCAC
10142P + 10142–10161 GAGTCTTCTAGCTATGCTCC
10763P + 10763–10782 ACTTTCTACCCATGCCACGC
10952N − 10952–10933 TGGCCGCAAGCACAAGAAGC
11995N − 12015–11995 CTAACCCAGATGCTACATACC
12681N − 12704–12681 GGTTCCTGGGTGGCTAATAACTAC
Nucleotides are numbered according to the published sequence of EAV030 (GenBank
ID Y07862) (van Dinten et al., 1997).
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Nucleotide sequences were assembled and manually edited using
CodonCode Aligner v2.0.2 (CodonCode Corporation, Dedham, MA). Se-
quences were editedwith BioEdit v7.0.5.3 (Hall, 1999) and the percent-
ages of the nucleotide identities were determined with EMBOSS
Pairwise Alignment Algorithms (http://www.ebi.ac.uk/Tools/emboss/
align/). Comparisons of the nucleotide and amino acid sequences
were performed with Vector NTI Advance® v11.5.1 (Invitrogen-Life
Technologies, Carlsbad, CA).
Phylogenetic analysis
Phylogenetic analysis was conducted using the partial ORF5 se-
quence of 518 nucleotides (nt numbers 11,296 to 11,813 according to
the sequence of the EAV030 strain referenced as Y07862 in GenBank).
A total of 388 EAV sequences were used to perform the phylogenetic
analysis: 322 from the GenBank database, and 66 additional sequences
of partial ORF5 from26 strains and 40 clones, provided in this study. The
GenBank accession numbers of these EAV strains have either been
reported previously or are provided in Table 1 (Pronost et al., 2010;
Zhang et al., 2007, 2010). The unrooted neighbor-joining tree and den-
drogram were constructed using MEGA4.1 and bootstrap analysis was
carried out on 1000 replicate data sets (Tamura et al., 2007).
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